Tintelnotia destructans: Clinical Spectrum, Laboratory Identification, and Antifungal Susceptibility

Tintelnotia destructans is a rare coelomycetous mold belonging to the family Phaeosphaeriaceae. Initially described from isolates associated with keratitis and onychomycosis, it has subsequently been reported in extraocular infections, including a maxillary sinus fungus ball and invasive rhinosinusitis in an immunocompromised child. This narrative review synthesizes the clinical, diagnostic, and therapeutic evidence and reassesses publicly available sequences through single-locus and concatenated phylogenetic analyses. Twelve clinical episodes were reconstructed: eight ocular episodes, one onychomycosis, one maxillary sinus fungus ball, one invasive rhinosinusitis, and one cutaneous isolation of uncertain clinical significance. Reported ocular predisposing factors included contact lens wear, trauma, pre-existing corneal damage, and corticosteroid exposure. Laboratory identification remains challenging because morphology is insufficient for species-level recognition and MALDI-TOF MS identification depends on suitable reference spectra. ITS, LSU, and RPB2 distinguished T. destructans from T. opuntiae within the analyzed dataset, whereas SSU did not resolve the two species. The four T. destructans isolates included in the concatenated analysis showed no sequence variation. Antifungal susceptibility results derive from few isolates tested using heterogeneous methods and endpoints, without species-specific interpretive criteria. Terbinafine MICs were consistently low, but clinical superiority cannot be established; echinocandin results are difficult to compare because reported endpoints differ. Treatment regimens were heterogeneous, and several keratitis episodes required penetrating keratoplasty despite antifungal therapy. More complete clinical reporting and standardized susceptibility testing are needed to clarify the epidemiology and guide management of this uncommon opportunistic mold.

Authors

Institutions

Publication Details

Journal
Microorganisms
Published
2026-11-18
DOI
https://doi.org/10.3390/microorganisms14112684
Primary Topic
Ocular Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tintelnotia destructans: Clinical Spectrum, Laboratory Identification, and Antifungal Susceptibility

Brunella Posteraro, Elena De Carolis, Maurizio Sanguinetti, Terenzio Cosio et al.
1 links
Microorganisms
Ocular Infections and Treatments
article

Tintelnotia destructans: Clinical Spectrum, Laboratory Identification, and Antifungal Susceptibility

Brunella Posteraro, Elena De Carolis, Maurizio Sanguinetti, Terenzio Cosio, Patrizia Posteraro
article en

Abstract

Tintelnotia destructans is a rare coelomycetous mold belonging to the family Phaeosphaeriaceae. Initially described from isolates associated with keratitis and onychomycosis, it has subsequently been reported in extraocular infections, including a maxillary sinus fungus ball and invasive rhinosinusitis in an immunocompromised child. This narrative review synthesizes the clinical, diagnostic, and therapeutic evidence and reassesses publicly available sequences through single-locus and concatenated phylogenetic analyses. Twelve clinical episodes were reconstructed: eight ocular episodes, one onychomycosis, one maxillary sinus fungus ball, one invasive rhinosinusitis, and one cutaneous isolation of uncertain clinical significance. Reported ocular predisposing factors included contact lens wear, trauma, pre-existing corneal damage, and corticosteroid exposure. Laboratory identification remains challenging because morphology is insufficient for species-level recognition and MALDI-TOF MS identification depends on suitable reference spectra. ITS, LSU, and RPB2 distinguished T. destructans from T. opuntiae within the analyzed dataset, whereas SSU did not resolve the two species. The four T. destructans isolates included in the concatenated analysis showed no sequence variation. Antifungal susceptibility results derive from few isolates tested using heterogeneous methods and endpoints, without species-specific interpretive criteria. Terbinafine MICs were consistently low, but clinical superiority cannot be established; echinocandin results are difficult to compare because reported endpoints differ. Treatment regimens were heterogeneous, and several keratitis episodes required penetrating keratoplasty despite antifungal therapy. More complete clinical reporting and standardized susceptibility testing are needed to clarify the epidemiology and guide management of this uncommon opportunistic mold.

MicroorganismsVol. 14(11)
Università Cattolica del Sacro Cuore (IT), Agostino Gemelli University Polyclinic (IT), Ospedale San Carlo (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Good health and well-being
Ocular Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon